Are you Dr. Waterfield?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 51 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1020 Southhill Dr
Ste 200
Cary, NC 27513Phone+1 919-659-1678- Is this information wrong?
Summary
- Dr. William Waterfield, MD is an oncologist in Cary, North Carolina. He is currently licensed to practice medicine in Wisconsin, Montana, and Tennessee. He is affiliated with MedStar Franklin Square Medical Center, St. Peter's Health, and HSHS Sacred Heart Hospital.
Education & Training
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1976 - 1977
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1975 - 1976
UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 1973 - 1975
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1972 - 1973
Lewis Katz School of Medicine at Temple UniversityClass of 1972
Certifications & Licensure
MD State Medical License 1979 - 2023
TN State Medical License 2013 - 2022
MT State Medical License 2016 - 2022
WA State Medical License 2012 - 2021
GA State Medical License 2013 - 2021
WI State Medical License 2017 - 2021
SD State Medical License Active through 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma Start of enrollment: 2010 Jun 22
Publications & Presentations
PubMed
- 68 citationsPatient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma: How Different are these From Conventional Treatment Responses?Gregory K. Pennock, William Waterfield> ;American Journal of Clinical Oncology. 2012 Dec 1
- 899 citationsIpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study, , , , , , , , , , , , , , , > ;The Lancet. Oncology. 2010 Feb 1
- Efficacy of ipilimumab 10 mg/kg in advanced melanoma patients (pts) with good and poor prognostic factors.Wolchok JD, de Pril V, Linette G, Waterfield W, Gajewski T, Chiarion-Sileni V, Ibrahim R, Chin K, Hoos A, Hamid O> ;J. Clin. Oncol.. 2009-05-20
- Join now to see all
Hospital Affiliations
MedStar Franklin Square Medical CenterRosedale, Maryland- St. Peter's HealthHelena, Montana
- HSHS Sacred Heart HospitalEau Claire, Wisconsin
- Aspirus Riverview Hospital and Clinics, Inc.Wisconsin Rapids, Wisconsin
